INSIGHTS ON QUALITY CONTROL
-
0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?
Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.
-
Seamlessly Integrating An E-WorkBook With A Customer's LIMS
Explore the story of a global biopharma company's integration of E-WorkBook with their LIMS, automating ADA study reports, saving significant time, and enhancing data accuracy.
-
Lentiviral Vector Upstream Process
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
A New Framework For Identifying Nitrosamine Risks And Derisking Products
Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.
-
Essential Insights Into Pharmaceutical Product Release: Part 21/13/2025
Optimizing pharmaceutical product release requires effective planning, specification development, electronic systems, and collaboration with CMOs, ensuring compliance, efficiency, and quality in the drug manufacturing process.
-
Contamination Control Strategies For Innovation And Regulatory Compliance3/4/2026
Creating a robust contamination control strategy is essential for pharmaceutical manufacturing. Learn to align risk management and technical controls to ensure lasting regulatory compliance.
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies2/26/2026
Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.
-
Aseptic Expertise And Delivery Of Services8/20/2024
A pharmaceutical services company sought expert intervention after a routine requalification of their aseptic simulation process revealed a contaminated unit, halting commercial production for two months.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer5/1/2026
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
QUALITY CONTROL SOLUTIONS
-
What is dissolution testing? Why is it critical? What should you consider for your method validation? Find answers to these questions and more in this quick guide to dissolution testing.
-
Advance organizational expertise with structured training designed for technical mastery. Explore specialized lessons that empower teams to optimize complex workflows and maintain compliance.
-
One (1) used Elizabeth Hata Elizatest Auto Sampler, model 3+, with (8) sample stations, with Mettler-Toledo scale, disposal bin, serial # ET3089707007
-
Ensure sterile integrity and personnel safety during hazardous drug handling. Optimize workflows with advanced containment technology that adapts to complex facility and processing requirements.
-
Traditional bioburden testing (or microbial limit testing) takes several days to grow visible colonies of microorganisms, so identifying these and initiating corrective action takes longer. The Milliflex® Quantum system quantitatively detects microbial contamination in filterable samples in as little as a third of the time it takes with traditional plate-based monitoring methods. The Milliflex® Quantum system is based on fluorescent staining of all viable microorganisms, making emerging microcolonies visible to the system when they’re still too small to be seen with the naked eye. After rapid detection, the colonies can be reincubated to grow into visible colonies and be identified by any method—an approach that cleverly combines rapid and compendial bioburden testing.